Home › Research › Digital health tools
Treatment of Alzheimer Disease With CT Scans: A Case Report
Cuttler JM, Moore ER, Hosfeld VD, Nadolski DL.. Dose-response : a publication of International Hormesis Society, 2016-04-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Alzheimer disease (AD) primarily affects older adults. This neurodegenerative disorder is the most common cause of dementia and is a leading source of their morbidity and mortality. Patient care costs in the United States are about 200 billion dollars and will more than double by 2040. This case report describes the remarkable improvement in a patient with advanced AD in hospice who received 5 computed tomography scans of the brain, about 40 mGy each, over a period of 3 months. The mechanism appears to be radiation-induced upregulation of the patient's adaptive protection systems against AD, which partially restored cognition, memory, speech, movement, and appetite.
What this study adds
Evidence grade: Low
This single case report describes improvement in one patient with advanced Alzheimer's disease in hospice after five brain CT scans over three months. A single case report cannot show that CT scans treat Alzheimer's disease, and no conclusion about curing or preventing the disease can be drawn.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Cuttler, J. M., Moore, E. R., Hosfeld, V. D., & Nadolski, D. L. (2016). Treatment of Alzheimer Disease With CT Scans: A Case Report. Dose-response : a publication of International Hormesis Society. https://doi.org/10.1177/1559325816640073
Vancouver
Cuttler JM, Moore ER, Hosfeld VD, Nadolski DL. Treatment of Alzheimer Disease With CT Scans: A Case Report. Dose-response : a publication of International Hormesis Society. 2016. doi:10.1177/1559325816640073. PMID: 27103883.
BibTeX
@article{cuttler2016-27103883,
author = {Cuttler, J. M. and Moore, E. R. and Hosfeld, V. D. and Nadolski, D. L.},
title = {{Treatment of Alzheimer Disease With CT Scans: A Case Report}},
journal = {Dose-response : a publication of International Hormesis Society},
year = {2016},
doi = {10.1177/1559325816640073},
pmid = {27103883},
url = {https://doi.org/10.1177/1559325816640073}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Alzheimer disease (AD) primarily affects older adults.
- This neurodegenerative disorder is the most common cause of dementia and is a leading source of their morbidity and mortality.
- Patient care costs in the United States are about 200 billion dollars and will more than double by 2040.
- This case report describes the remarkable improvement in a patient with advanced AD in hospice who received 5 computed tomography scans of the brain, about 40 mGy each, over a period of 3 months.
- The mechanism appears to be radiation-induced upregulation of the patient's adaptive protection systems against AD, which partially restored cognition, memory, speech, movement, and appetite.
Why it matters
This single case report describes improvement in one patient with advanced Alzheimer's disease in hospice after five brain CT scans over three months. A single case report cannot show that CT scans treat Alzheimer's disease, and no conclusion about curing or preventing the disease can be drawn.
New to this subject? Start with our plain-English guide: Digital health →
Study details
- Study designcase report
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 36 of the 96 points we could judge it on, which is 38 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Dose-response : a publication of International Hormesis Society) |
| Journal's citation record | 0 / 4 | Dose-Response: journal h-index 66 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | Design recorded as “case report”, which our rubric does not rank (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2016 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 4 / 7 | Cited 65 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.4 citations a year over 12 year(s) since 2016 |
| Impact for its field and year | 3 / 6 | Cited 3.9× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 2 / 4 | Cited 20 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | — / 4 | OpenAlex's profile for last-listed author David L. Nadolski holds only 3 work(s), too few to judge a track record — left out of this score |
| Institution's track record | 0 / 3 | Dow Chemical (United States): institution h-index 280 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 27103883) |
| Free to read | 2 / 2 | Free to read |
| Points | 36 / 96 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 36 of the 96 points we could judge it on is 38 out of 100. |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Digital health tools from nearby years
Also in Digital health tools
178 studies in the library are filed under Digital health tools with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Digital health tools hub.